| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 297-303, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
RF Chuaqui, Z Zhuang, MR Emmert-Buck, LA Liotta and MJ Merino
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20814, USA.
Identical allelic loss in invasive and adjacent in situ ductal breast carcinoma (DCIS) on chromosome 11q13 has been previously reported, providing molecular evidence for the progression of DCIS to invasive tumor. In this study we analyzed loss of heterozygosity (LOH) on 11q13 (PYGM, INT-2) in atypical ductal hyperplasia (ADH) and various histological types of in situ carcinomas of the breast in patients without invasive cancer. Twenty-four cases of in situ carcinoma and twelve cases of ADH were studied. Tissue microdissection of normal, hyperplastic, and tumor cells from fixed, paraffin-embedded sections was performed, and DNA was extracted for polymerase chain reaction. In situ tumors included both high- and low-grade DCIS. LOH was identified in six of twenty-two (27.3%) in situ tumors and in one of eleven (9%) ADH cases. Within in situ carcinomas, LOH was identified in six of seventeen (35%) high-grade DCIS but in none of six low-grade DCIS. The present results show that LOH at 11q13 occurs in an appreciable proportion of high-grade DCIS, although the rate is substantially less than in patients with concomitant DCIS and invasive tumor. LOH was identified less frequently in low-grade in situ tumors and ADH, suggesting that a putative tumor suppressor gene(s) located on chromosome 11q13 may be involved in the transition from early preneoplastic lesions to invasive breast cancer.
This article has been cited by other articles:
![]() |
G. Arpino, R. Laucirica, and R. M. Elledge Premalignant and In Situ Breast Disease: Biology and Clinical Implications Ann Intern Med, September 20, 2005; 143(6): 446 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Ellsworth, D. L. Ellsworth, D. M. Neatrour, B. Deyarmin, S. M. Lubert, M. J. Sarachine, P. Brown, J. A. Hooke, and C. D. Shriver Allelic Imbalance in Primary Breast Carcinomas and Metastatic Tumors of the Axillary Lymph Nodes Mol. Cancer Res., February 1, 2005; 3(2): 71 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Buerger, H Schmidt, A Beckmann, K S Zanker, W Boecker, and B Brandt Genetic characterisation of invasive breast cancer: a comparison of CGH and PCR based multiplex microsatellite analysis J. Clin. Pathol., November 1, 2001; 54(11): 836 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
S R Lakhani Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer Mol. Pathol., October 1, 2001; 54(5): 281 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gong, S. DeVries, K. L. Chew, I. Cha, B.-M. Ljung, and F. M. Waldman Genetic Changes in Paired Atypical and Usual Ductal Hyperplasia of the Breast by Comparative Genomic Hybridization Clin. Cancer Res., August 1, 2001; 7(8): 2410 - 2414. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Maluf and F. Koerner Lobular Carcinoma in Situ and Infiltrating Ductal Carcinoma: Frequent Presence of DCIS as a Precursor Lesion International Journal of Surgical Pathology, April 1, 2001; 9(2): 127 - 131. [Abstract] [PDF] |
||||
![]() |
C. Washington, F. Dalbegue, F. Abreo, J. K. Taubenberger, and J. H. Lichy Loss of Heterozygosity in Fibrocystic Change of the Breast : Genetic Relationship Between Benign Proliferative Lesions and Associated Carcinomas Am. J. Pathol., July 1, 2000; 157(1): 323 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Buerger, R Simon, K-L Schäfer, R Diallo, R Littmann, C Poremba, P J van Diest, B Dockhorn-Dworniczak, and W Böcker Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast Mol. Pathol., June 1, 2000; 53(3): 118 - 121. [Abstract] [Full Text] |
||||
![]() |
M. G. Tibiletti, F. Sessa, B. Bernasconi, R. Cerutti, B. Broggi, D. Furlan, F. Acquati, M. Bianchi, A. Russo, C. Capella, et al. A Large 6q Deletion Is a Common Cytogenetic Alteration in Fibroadenomas, Pre-malignant Lesions, and Carcinomas of the Breast Clin. Cancer Res., April 1, 2000; 6(4): 1422 - 1431. [Abstract] [Full Text] |
||||
![]() |
N. Shivapurkar, S. Sood, I. I. Wistuba, A. K. Virmani, A. Maitra, S. Milchgrub, J. D. Minna, and A. F. Gazdar Multiple Regions of Chromosome 4 Demonstrating Allelic Losses in Breast Carcinomas Cancer Res., August 1, 1999; 59(15): 3576 - 3580. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Santamaria, G. Velasco, A. M. Pendas, A. Paz, and C. Lopez-Otin Molecular Cloning and Structural and Functional Characterization of Human Cathepsin F, a New Cysteine Proteinase of the Papain Family with a Long Propeptide Domain J. Biol. Chem., May 14, 1999; 274(20): 13800 - 13809. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. F. Newsham The Long and Short of Chromosome 11 in Breast Cancer Am. J. Pathol., July 1, 1998; 153(1): 5 - 9. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |